All News

Surat’s New Civil Hospital to produce its own oxyg

The New Civil Hospital (NCH) in Surat will now be producing its own oxygen which is likely to reduce
Read More

Aptinyx’s Mid-Stage NMDA Receptor Fails to Hit End

Shares of Illinois-based Aptinyx have plunged more than 67 percent in premarket trading after the co
Read More

Sanofi palms off MyoKardia heart disease pact

The decision comes ahead of data readouts for two of the clinical candidates – mavacamten and MYK-49
Read More

AbbVie Forges $105 Million+ CD39 Inhibitor Allianc

Privately-held Tizona Therapeutics snagged $105 million in upfront cash as its cancer antibody TTX-0
Read More

BioNTech Teams up With Sanofi to Target Solid Tumo

Days ahead of the J.P. Morgan Healthcare Conference, Germany-based BioNTech extended its three-year-
Read More

Selecta Biosciences' New CEO Restructures, Cuts 36

Selecta Biosciences, based in Watertown, Mass., announced that as part of restructuring efforts it i
Read More

After Announcing a New CEO, UroGen Touts Positive

UroGen Pharma, based in New York, announced positive topline results from its Phase III OLYMPUS clin
Read More


;